Evidence map›Paper›PMID 30696826›Full record

ArticleNPJ schizophrenia2019

The expression of long noncoding RNA NEAT1 is reduced in schizophrenia and modulates oligodendrocytes transcription.

Pavel Katsel, Panos Roussos, Peter Fam, Sonia Khan, Weilun Tan, Tetsuro Hirose, Shinichi Nakagawa, Mikhail V Pletnikov, Vahram Haroutunian

Open access · goldAbstract read
In one paragraph

Article in NPJ schizophrenia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. The Regulatory Potential of Long Non-Coding RNAs in Bipolar Disorder.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Oligodendrocyte-specific expression ofNon-coding RNA research · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Pavel KatselDepartment of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, USA. pavel.katsel@mssm.edu.
Panos RoussosDepartment of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-4640-6239
Peter FamMental Illness Research, Education and Clinical Center (MIRECC), James J Peters VA Medical Center, Bronx, NY, USA.
Sonia KhanDepartment of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Weilun TanDepartment of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Tetsuro HiroseInstitute for Genetic Medicine, RNA Biology Laboratory, Hokkaido University, Sapporo, 060-0815, Japan.
Shinichi NakagawaInstitute for Genetic Medicine, RNA Biology Laboratory, Hokkaido University, Sapporo, 060-0815, Japan.
Mikhail V PletnikovDepartments of Psychiatry, Neuroscience, Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Vahram HaroutunianDepartment of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-5860-2512
Icahn School of Medicine at Mount Sinai · USHokkaido University · JPJames J. Peters VA Medical Center · USAllen Institute for Brain Science · USJohns Hopkins University · US

Funding

Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
Role of DISC1 and NRG1 in oligodendrocyte development in schizophreniaR01MH097997 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KATSEL, PAVEL LEON · 2013 to 2017
$1.5M
Center for Integrated Healthcare, U.S. Department of Veterans Affairs (VISN 2 Center for Integrated Healthcare) MIRECCNIH HHS S10 OD018522NIMH NIH HHS R01 MH097997U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH097997
6 · The paper itself

Abstract

Oligodendrocyte (OLG)-related abnormalities have been broadly observed in schizophrenia (SZ); however, the etiology of these abnormalities remains unknown. As SZ is broadly believed to be a developmental disorder, the etiology of the myelin abnormalities in SZ may be related to OLG fate specification during development. Noncoding RNAs (ncRNAs) are an important part of multifaceted transcriptional complexes participating in neurogenic commitment and regulation of postmitotic cell function. The long ncRNA, NEAT1, is a structural component of paraspeckles (subnuclear bodies in interchromatin regions) that may control activity of developmental enhancers of OLG fate specification. Gene expression studies of multiple cortical regions from individuals with SZ showed strong downregulation of NEAT1 levels relative to controls. NEAT1-deficient mice show significant decreases in the numbers of OLG-lineage cells in the frontal cortex. To gain further insight into biological processes affected by NEAT1 deficiency, we analyzed RNA-seq data from frontal cortex of NEAT1

Identifiers

PMID30696826
PMCPMC6386752
OpenAlexW2912845754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.